(Received for publication September 14, 1992) Staurosporine, a potent inhibitor of protein kinases, has been reported to increase the accumulation of vincristine in multidrug-resistant (MDR) tumor cells and to bind P-glycoprotein, which works as an effluxpump in the plasma membrane of MDRcells1}. We have recently reported that N-ethoxycarbonyl-7-oxostaurosporine (NA-382) which has a low but selective inhibitory activity on protein kinase C, potently inhibits the function of P-glycoprotein2). Since P-glycoprotein is phosphorylated by protein kinase C3), it is important to discover whether the drug accumulation by these compounds is concerned with the inhibition of protein kinase C or not. We investigated in this study the effects of several staurosporine derivatives on protein kinase C, protein kinase A, and MDR.
Staurosporine derivatives used in this study are shown in Scheme 1. 7-Oxostaurosporine was synthesized from staurosporine in our laboratory by the known method4), and the other derivatives NA-381, NA-382, NA-478 and NA-460 were also synthesized from staurosporine by simple methods5).
At first, the inhibitory activities of these staurosporine derivatives on protein kinase A and protein kinase C were measured by the method described in a previous report2). As shownin Fig. 1 shows the profiles of the dose-dependent effects of NA-38 1 on VBL accumulation in parental P388 cells (P388/S) and P388/ADR cells.
These results indicated that there was no correlation between the protein kinase inhibitory activities and the effect on VBLaccumulation in MDRcells. Then we investigated the mechanism of VBLaccumulation using a photolabeling agent of P-glycoprotein6), azidopine, which is useful for research on MDRmodifiers. As shown in Fig. 2 
